Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 204599
Company: CHARTWELL MOLECULAR
Company: CHARTWELL MOLECULAR
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 2.5MG/5ML | SOLUTION;ORAL | Prescription | AA | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/15/2017 | ORIG-1 | Approval |
Label is not available on this site. |
LEVOCETIRIZINE DIHYDROCHLORIDE
SOLUTION;ORAL; 2.5MG/5ML
TE Code = AA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 2.5MG/5ML | SOLUTION;ORAL | Prescription | No | AA | 204599 | CHARTWELL MOLECULAR |
LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 2.5MG/5ML | SOLUTION;ORAL | Prescription | No | AA | 091263 | PADAGIS US |
LEVOCETIRIZINE DIHYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 2.5MG/5ML | SOLUTION;ORAL | Prescription | No | AA | 202673 | TARO |
LEVOCETIRIZINE HYDROCHLORIDE | LEVOCETIRIZINE DIHYDROCHLORIDE | 2.5MG/5ML | SOLUTION;ORAL | Prescription | No | AA | 210914 | HETERO LABS LTD III |